Google Ads for Naturopathic Clinics: What You Can (and Can’t) Advertise in 2026
Can naturopathic clinics run Google Ads?
Yes. Naturopathic clinics can run Google Ads for wellness consults, nutrition counseling, licensed primary care, acupuncture and lifestyle medicine, but not for compounded peptides, NAD+, stem cell or exosome therapy, regenerative PRP, hCG for weight loss or ephedra.
Table of Contents
Key takeaways
- Permanently banned regardless of certification: compounded peptides (BPC-157, TB-500, ipamorelin, sermorelin), NAD+, stem cell or exosome therapy, PRP marketed as regenerative, hCG for weight loss and ephedra (Stethon compliance runbook, verified 2026-05-06).
- One NAD+ line on an IV menu triggers Google’s speculative-treatment policy for the whole campaign.
- Framing traps: “anti-aging,” “longevity” and symptom-quiz forms turn advertisable services into rejections; quizzes also create HIPAA Marketing Rule exposure.
- Rx telehealth (semaglutide, HRT, TRT) needs LegitScript Healthcare Merchant certification ($975 application plus $2,150 a year per site, October 2026) and Rx Drug Services certification first.
- Budget anchor: healthcare Search runs about $5.64 CPC, 6.07% CTR, 8.09% CVR and $66.02 per lead (LocaliQ, October 2024 to September 2025).
The permanent-ban list every naturopathic clinic must check before spending a dollar
Naturopathic menus often mix licensed primary care with regenerative and longevity add-ons, and Google treats them differently. Six common offerings are permanent bans, not gray areas a landing page can talk around.
| Service | Status | Why |
|---|---|---|
| Compounded peptides (BPC-157, TB-500, ipamorelin, sermorelin) | Permanently banned | Unapproved compounded-drug claims fall under Google’s healthcare and medicines policy; no certification lifts this. |
| NAD+ (injection, IV, nasal spray, oral) | Permanently banned | Classified under Google’s speculative and unproven treatment policy; also pulls any IV menu containing it into rejection. |
| Stem cell / exosome therapy | Permanently banned | Unsubstantiated regenerative claims; carries FDA warning-letter exposure alongside the ad rejection. |
| PRP marketed as “regenerative medicine” | Permanently banned as framed | PRP has legitimate clinical uses; the “regenerative” outcome claim is what triggers rejection. |
| hCG for weight loss | Permanently banned | Off-label prescribing risk plus FDA warnings on hCG weight-loss marketing. |
| Ephedra | Permanently banned | Listed substance under Google’s dangerous-products and healthcare policy. |
| General wellness consults, nutrition counseling | Advertisable | Standard healthcare services policy; no drug or outcome claim involved. |
| Licensed-ND primary care (state-licensed) | Advertisable | Standard healthcare services policy; verify licensure claims match the state’s actual scope. |
| Semaglutide / HRT / TRT telehealth | Advertisable with certification | Requires LegitScript Healthcare Merchant plus Rx Drug Services certification before campaigns can run. |
IV menus need extra care. Listing NAD+ next to vitamin drips, Myers’ cocktails and hydration IVs makes Google’s speculative-treatment policy read the whole page as one offering, so one line item can take down every ad in the group, legal services included (Stethon compliance runbook, verified 2026-05-06).
What we won’t do: run paid ads for a clinic whose advertised menu includes a permanent-ban item. The item comes off ad-facing menus and landing pages, or paid waits. Hoping review misses it is how clinics lose entire accounts, sometimes permanently.
The naturopathic advertising paradox
Demand for naturopathic doctors, integrative wellness and hormone optimization keeps growing, yet platforms treat much of the typical menu as risky. A clinic can run profitable campaigns for nutrition counseling and acupuncture while NAD+ and peptides stay banned under any framing.
The Stethon Take: most naturopathic suspensions we review are self-inflicted: one banned item in an unchecked services list. The fix is a free menu edit.
The framing traps that turn a legal service into a banned claim
Legal to perform doesn’t mean advertisable however you like. Hormone optimization, IV nutrient therapy and lifestyle medicine are advertisable; the language gets them rejected. Four patterns cause most rejections:
- “Anti-aging,” “longevity,” “healthspan,” “reverse aging” read as unsubstantiated outcome claims, even on legitimate services.
- “Cure” and “guaranteed” violate policy on any health service.
- Before/after photos imply guaranteed outcomes and draw aesthetic-medicine scrutiny.
- Symptom-quiz forms collect health detail before any clinical relationship, risking lead-form policy and HIPAA Marketing Rule exposure once tied to contact details.
Change the claim, not the service. “Restore energy and metabolic balance” clears review; “reverse the aging process” doesn’t.
What a compliant naturopathic Google Ads campaign actually looks like
A compliant account gets four things right:
- Structure: one ad group and landing page per advertisable service line (wellness consults, nutrition counseling, licensed-ND primary care where allowed, acupuncture, lifestyle medicine), not per disease or protocol.
- Keywords: local, service-based intent (“naturopathic doctor [city],” “nutrition counseling near me”), not condition-led terms.
- Landing pages: describe the visit, not the outcome. “Schedule a naturopathic wellness consultation” passes; “reverse your chronic fatigue naturally” doesn’t.
- Tracking: fire on generic actions (form submitted, call started, appointment booked), never health events like “symptom quiz completed.”
The Stethon Way: before launch we check the full offering against our compliance runbook line by line. Banned items come off ad-facing pages, or the engagement stays organic and GBP-only. That is why our accounts stay out of suspension review.
The certification path for Rx telehealth services
Prescription telehealth (semaglutide, HRT or TRT through a supervising prescriber) is advertisable, but only after certification.
Google requires LegitScript Healthcare Merchant certification ($975 application fee plus $2,150 a year per website, as of October 2026) plus Rx Drug Services certification for the drug category. Hims & Hers, Ro and Midi Health run compliant campaigns on this path.
Start certification first and set the launch date around the certifier’s response; you don’t control that review.
Budget math: cost anchors and when organic beats paid
Those benchmarks ($5.64 CPC, 6.07% CTR, 8.09% CVR, about $66.02 per lead) are category-wide, not naturopathic-specific, but they anchor a first budget: $4,000 a month in Search should yield roughly 60 leads before local competition and landing page quality move it.
Stethon’s PPC program sets a minimum spend so a 30-day window yields enough leads to read, not two leads and no signal.
The Stethon Take: we turn down naturopathic paid engagements more often than most agencies admit. If most of the menu is banned and won’t change, paid has nothing to sell; organic content and GBP can still market the full menu, since ad policy doesn’t apply to them.
FAQ
Can naturopathic clinics run Google Ads for NAD+ therapy?
No. NAD+ is a permanent ban on Google Ads in every form, injection, IV, nasal spray, or oral, regardless of who administers it or what certification the clinic holds (Stethon compliance runbook, verified 2026-05-06).
Why does one banned service affect an entire ad campaign?
Google’s review process evaluates the landing page an ad links to, not just the ad copy. A page listing NAD+ next to otherwise advertisable IV services can pull ads pointing to that page into rejection for association, even ads promoting a legal service. Dropping banned items from ad-facing pages entirely prevents this.
What naturopathic services can run compliant Google Ads campaigns?
General wellness consults, nutrition counseling, licensed-ND primary care where state law permits it, acupuncture, and lifestyle-medicine programs are all advertisable under Google’s standard healthcare policy. Frame the ad and landing page around the visit and the service, not a disease-reversal or anti-aging outcome.
What does certification cost for Rx telehealth services like semaglutide or TRT?
LegitScript lists a $975 application fee plus a $2,150 annual fee per website (as of October 2026), plus a separate Rx Drug Services certification for the specific prescription category. The pricing page offers expedited processing for an additional $2,500 per application, which starts the review within 2 business days of submission, and gives no completion timeline, so start certification before you set a launch date.
Should every naturopathic clinic run paid ads?
No. A clinic whose advertised offering is mostly permanent-ban items, and unwilling to restructure that menu, has little left for paid media to sell. Organic content and Google Business Profile can market that same full menu without triggering ad policy.
Work with an agency that audits the offering before it audits the ad account
Most naturopathic account losses share one cause: no one checked the menu against current policy. Our healthcare Google Ads program audits the offering before launch and ties tracking to our HIPAA and privacy compliance guide. Clinics with a regenerative line should also read the regenerative medicine marketing guide.
Editorial disclaimer
Produced by Stethon Digital Marketing (healthcare performance marketing). Updated October 2026.
This guide is marketing guidance based on publicly available Google Ads policy, published certification pricing, and Stethon Digital Marketing’s operating practices as of July 2026. It is not legal advice, platform policy changes without notice, and clinics should verify current Google Ads healthcare and medicines policy directly with qualified counsel before launching any naturopathic ad campaign.
Stethon Digital Marketing Team
Healthcare SEO, PPC & Paid Social Specialists
Stethon Digital Marketing delivers SEO, PPC and social media advertising for independent healthcare practices across the United States. This guide draws on our hands-on campaign work and the primary sources cited throughout.